| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 226,661 | 192,949 | 173,253 | 192,166 | | Cost of Revenue | 103,321 | 96,514 | 89,286 | 87,379 | | | Gross Profit | 123,340 | 96,435 | 83,967 | 104,787 | | | Operating Expenses | | Research Development | 29,568 | 27,636 | 25,656 | 26,973 | | Selling General and Administrative | 41,046 | 36,383 | 33,336 | 36,840 | | Non Recurring |
-
| 1,238 | 5,934 | 500 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 52,726 | 31,178 | 19,041 | 40,474 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,586 | 8,996 | 16,392 | (12,968) | | Earnings Before Interest And Taxes | 59,312 | 40,174 | 35,433 | 27,506 | | Interest Expense | 8,030 | 7,519 | 6,511 | 5,775 | | Income Before Tax | 51,282 | 32,655 | 28,922 | 21,731 | | Income Tax Expense | 6,797 | 5,287 | 6,093 | (51,438) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 44,485 | 27,368 | 22,829 | 73,169 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 44,485 | 27,368 | 22,829 | 73,169 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $44,485 | $27,368 | $22,829 | $73,169 |
|
0.20% Nasdaq 
Income Statement
